-
Loading metrics
Open Access
Peer-reviewed
Research Article
A novel TREX1 inhibitor, VB-85680, upregulates cellular interferon responses
-
Stephen Flowers ,
Roles Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Supervision, Validation, Visualization, Writing – original draft, Writing – review & editing
* E-mail: sflowers@mdlab.com
Affiliation Oncoveda, A Division of Genesis Research & Development Institute, LLC, Hamilton, New Jersey, United States of America
⨯ -
Brenda A. Petronella,
Roles Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Supervision, Validation, Visualization, Writing – original draft, Writing – review & editing
Affiliation Venenum Biodesign, LLC, and Genesis Drug Discovery & Development, LLC, Hamilton, New Jersey, United States of America
⨯ -
Michael S. McQueney,
Roles Conceptualization, Project administration, Supervision, Writing – review & editing
Affiliation Oncoveda, A Division of Genesis Research & Development Institute, LLC, Hamilton, New Jersey, United States of America
⨯ -
Barbara Fanelli,
Roles Investigation
Affiliation Oncoveda, A Division of Genesis Research & Development Institute, LLC, Hamilton, New Jersey, United States of America
⨯ -
Warren Eisenberg,
Roles Investigation
Affiliation Venenum Biodesign, LLC, and Genesis Drug Discovery & Development, LLC, Hamilton, New Jersey, United States of America
⨯ -
Albert Uveges,
Roles Investigation
Affiliation Venenum Biodesign, LLC, and Genesis Drug Discovery & Development, LLC, Hamilton, New Jersey, United States of America
⨯ -
Allison L. Roden,
Roles Investigation
Affiliation Oncoveda, A Division of Genesis Research & Development Institute, LLC, Hamilton, New Jersey, United States of America
⨯ -
Scott Salowe,
Roles Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Supervision, Validation, Writing – review & editing
Affiliation Venenum Biodesign, LLC, and Genesis Drug Discovery & Development, LLC, Hamilton, New Jersey, United States of America
⨯ -
Venu Bommireddy,
Roles Conceptualization, Formal analysis, Methodology, Writing – review & editing
Affiliation Oncoveda, A Division of Genesis Research & Development Institute, LLC, Hamilton, New Jersey, United States of America
⨯ -
Jeffrey J. Letourneau,
Roles Conceptualization, Formal analysis, Resources, Writing – review & editing
Affiliation Venenum Biodesign, LLC, and Genesis Drug Discovery & Development, LLC, Hamilton, New Jersey, United States of America
⨯ -
Chia-Yu Huang,
Roles Conceptualization, Project administration, Supervision
Affiliation Venenum Biodesign, LLC, and Genesis Drug Discovery & Development, LLC, Hamilton, New Jersey, United States of America
⨯ -
James R. Beasley
Roles Conceptualization, Project administration, Supervision
Affiliation Venenum Biodesign, LLC, and Genesis Drug Discovery & Development, LLC, Hamilton, New Jersey, United States of America
⨯
A novel TREX1 inhibitor, VB-85680, upregulates cellular interferon responses
- Stephen Flowers,
- Brenda A. Petronella,
- Michael S. McQueney,
- Barbara Fanelli,
- Warren Eisenberg,
- Albert Uveges,
- Allison L. Roden,
- Scott Salowe,
- Venu Bommireddy,
- Jeffrey J. Letourneau
- Published: August 23, 2024
- https://doi.org/10.1371/journal.pone.0305962